Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA bindingRakesh K Sharma, Masami Otsuka, Vineet Pande, et al.Journal of Computer-Aided Molecular Design|May 6, 2004
A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA bindingVineet Pande, Rakesh K Sharma, Jun-Ichiro Inoue, et al.Current Opinion in Structural Biology|January 8, 2025
Computational advances in discovering cryptic pockets for drug discoveryMartijn P Bemelmans, Zoe Cournia, Kelly L Damm-Ganamet, et al.Journal of Molecular Biology|February 19, 2008
Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegiaJenny A Korhonen, Vineet Pande, Teresa Holmlund, et al.Proteins|February 10, 2024
Application of AlphaFold models in evaluating ligandable cysteines across E3 ligasesPatrick Koldenhof, Martijn P Bemelmans, Brahma Ghosh, et al.The Journal of Organic Chemistry|November 16, 2020
Synthesis and Reactivity of Spirocarbocycles as Scaffolds for Nucleoside AnaloguesJonas Verhoeven, Xavier Deraet, Vineet Pande, et al.Journal of Medicinal Chemistry|June 9, 2006
Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationshipsRakesh K Sharma, Shilpa Chopra, Som D Sharma, et al.Bioorganic Chemistry|March 25, 2005
Inhibitory activity of polyhydroxycarboxylate chelators against recombinant NF-kappaB p50 protein-DNA bindingRakesh K Sharma, Vineet Pande, Maria J Ramos, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 15, 2019
Preparation of 4'-Spirocyclobutyl Nucleoside Analogues as Novel and Versatile Adenosine ScaffoldsJonas Verhoeven, Freija De Vleeschouwer, Hanchu Kong, et al.Journal of Chemical Theory and Computation|October 30, 2023
Alchemical Free Energy Calculations on Membrane-Associated ProteinsMichail Papadourakis, Hryhory Sinenka, Pierre Matricon, et al.Pageof 4